**Core tip:**Celiac artery variation has been given great importance by surgeons. However, the distribution of the lymph nodes around the variant celiac artery and its effect on prognosis has rarely been examined. This study shows that variation of the celiac artery is an important factor affecting the lymph node clearance of gastric cancer, and the decrease in the number of lymph nodes dissection does not affect the prognosis. Therefore, lymph nodes dissection around abnormal hepatic artery, especial for the abnormal hepatic artery derived from the superior mesenteric artery, is not recommended.

INTRODUCTION
============

Gastric cancer is the fifth most common malignant tumor, and its mortality rate ranks second in the world. In 2015 alone, 679,000 new cases were estimated in China, and about 498,000 patients died of gastric cancer\[[@B1]\]. Radical D2 lymphadenectomy as a standard procedure has gained global consensus. The current seventh edition of the International Union against Cancer/American Joint Committee on Cancer (UICC/ AJCC) tumor, node, and metastases (TNM) staging for gastric cancer recommended that at least 16 or more lymph nodes should be dissected for satisfactory histological examination\[[@B2]\]. A German multicenter study showed that clearance of more than 25 lymph nodes was an independent prognostic factor for all types of pathological staging\[[@B3]\]. Studies showed that the number of lymph nodes dissection directly affected the prognosis and recurrence of gastric cancer\[[@B4]\].

According to our previous results\[[@B5]\], there was no obvious lymph node around the abnormal hepatic artery derived from the superior mesenteric artery, and the relationship was unclear between the total number of lymph nodes dissection and the impact on the prognosis in celiac artery variation patients. In addition, Arifuzzamanet al\[[@B6]\] found that the celiac artery variation rate was 30.9%, suggesting that it may be important clinically to investigate the difference in the number of lymph nodes dissection in patients with celiac artery variation and those with normal vessels. These findings could provide clinical basis for precise individualized lymph nodes dissection of gastric cancer.

MATERIALS AND METHODS
=====================

General information
-------------------

Four hundred and fifty-two gastric cancer patients who underwent D2 lymphade-nectomy that was performed by the same surgical team at the Department of Gastrointestinal Surgery of the First Affiliated Hospital of Guangxi Medical University from January 2009 to March 2017 were included in this study and screened according to the following criteria: (1) Preoperative gastroscopic pathology was gastric carcinoma; (2) Patient underwent upper abdominal multi-slice spiral computed tomography angiography(MSCTA) examination; (3) Preoperative comprehensive evaluations indicated D2 lymphadenectomy; (4) Patient was adopted for D2 lymphadenectomy. For the patients with vascular variations, we carefully dissected and cleaned the surrounding lymph nodes during the operation; (5) Complete clinical and pathological data were recorded; (6) No neoadjuvant therapy was accepted; and (7) Excluding other malignant tumors. Finally, 421 cases satisfied the conditions mentioned above. Three hundred and six cases (72.7%) were men, and the median age was 56.1 years old (19-86 years old). After the surgery, all the patients were staged according to the 7^th^ AJCC TNM staging standard: IA stage-49 cases, IB stage-41 cases, IIA stage-47 cases, IIB stage-62 cases, IIIA stage-52 cases, IIIB stage-56 cases, and 114 in stage IIIC. This study was approved by ethical review committee at 27 August 2018 \[Approval number: 2018(KY-E-056)\].

Information acquisition of celiac artery
----------------------------------------

Inspection equipment (LightspeedVCT) was provided by the American GE company. The preparation, scanning parameters, and data and image processing of the CT scan have been detailed in the literature\[[@B7]\]. After image reconstruction, two senior radiologists analyzed the reconstructed three-dimensional vascular images and observed whether celiac artery variation was present.

Surgery
-------

The 421 gastric cancer patients underwent standard radical gastrectomy by the same experienced surgical team. Lymph node clearance was carried out according to the requirements of the Japanese Gastric Cancer Association protocol. The range of lymph nodes dissection and gastrectomy were performed in accordance with the requirements of the Japanese Gastric Cancer Association guidelines\[[@B8]\]. The lymph nodes in each group were selected by the senior resident who participated in the operation, in accordance with the regulations of the Japanese gastric cancer protocol at the end of the operation. After the operation, additional sorting was carried out with touch method, and the lymph nodes extracted in the operation were sent for pathological examination.

Follow up
---------

The standard follow-up protocol for patients with gastric cancer was every 3 mo for at least 2 years, every 6 mo for the next 3 years, and every 12 mo after five years for life.The follow-up items included physical examination, tumor markers, computed tomographic scan, and gastroscopy. Follow-up deadline was to 31 May 2018, and the survival time was calculated from operation time to death or follow-up deadline. Sixteen cases were lost midway during follow-up, and the loss rate was 3.8%. The patients were followed up for 12.0-112.0 mo, and the median follow-up period was 42.6 mo.

Statistical analysis
--------------------

SPSS 16 statistical software (Chicago, IL, United States) was used to analyze the data. The count data was compared by *χ*^2^ test. Two independent samples *t* test or one-way analysis of variance were used to analyze normal distribution data. Survival analysis was performed by Kaplan-Meier method, and survival rate was compared by Log-rank. Univariate and multivariate Cox regression analysis was used to analyze the survival of gastric cancer. The difference was statistically significant if *P* \< 0.05.

RESULTS
=======

The variation of celiac artery
------------------------------

The preoperative MSCTA images showed 311 cases of normal celiac artery, 110 cases of variant celiac artery, and the variation rate was 26.13%. Celiac artery types in all 421 cases detected by preoperative MSCTA were conformed intraoperatively. Ninety-seven cases had an abnormal hepatic artery and were classified according to Hiatt's standard\[[@B9]\] (Figure [1](#F1){ref-type="fig"}). Among them, abnormal hepatic artery derived from superior mesenteric artery was seen in 48 cases, the hepatic artery ran in front of the pancreas in two cases(Figure [2](#F2){ref-type="fig"}) and behind the pancreas in 46 cases. In the post-pancreas type, the hepatic artery arising from the superior mesenteric artery ran behind the pancreatic neck and the initial segment of the portal vein. Then, it ran behind the right hepatic duct and entered the liver ligament.

![Abnormal types of hepatic artery.](WJGO-11-499-g001){#F1}

![The common hepatic artery derived from the superior mesenteric artery (anterior-pancreas type).](WJGO-11-499-g002){#F2}

The left gastric artery derived from the abdominal aorta in eight cases, the splenic artery derived from the superior mesenteric artery in two cases, and in three cases, the celiac trunk and the superior mesenteric artery with a common trunk derived from the abdominal aorta directly.

The relationship between the number of lymph nodes dissection and the clinicopathological features of radical D2 lymphadenectomy for gastric cancer
---------------------------------------------------------------------------------------------------------------------------------------------------

In total, 2243 lymph nodes were dissected in 110 cases of celiac artery variation, with an average of 20.4 (4-50)/case, 671 positive lymph nodes, and 6.1 average lymph node metastases. The total number of lymph nodes detection in 311 cases without vascular variation was 7373, with an average of 23.7 (3-70/case), 1663 positive lymph nodes, and 5.3 average lymph node metastases. In general, the number of lymph nodes dissection in patients with celiac artery variation was significantly less than that in patients without celiac artery variation (*P* = 0.000). In stage I and II, there was significant difference between the two groups of lymph node clearance (*P* = 0.000),but there was no significant difference in stage III (*P* = 0.229). There was no significant difference in age, sex, tumor location, tumor stage, pathological type, Borrmann typing, or adjuvant chemotherapy between the two groups (*P* \> 0.05) (Table [1](#T1){ref-type="table"}).

###### 

Comparison of clinical data between two groups of patients with celiac artery variation and without vascular variation

  **Clinicopathological features**           **Abnormal vessel group, *n* = 110**   **Normal vessel group, *n* = 311**   ***χ*^2^**   ***P* value**
  ------------------------------------------ -------------------------------------- ------------------------------------ ------------ ---------------
  Gender                                                                                                                              
  male                                       74                                     232                                  2.196        0.138
  female                                     36                                     79                                                
  Agein yr                                                                                                                            
  ≤45                                        23                                     54                                   0.881        0.644
  46-60                                      46                                     143                                               
  \>60                                       41                                     114                                               
  Tumor stage                                                                                                                         
  I                                          24                                     66                                   2.848        0.241
  II                                         22                                     87                                                
  III                                        64                                     158                                               
  Tumor location                                                                                                                      
  Proximal stomach                           13                                     38                                   0.977        0.802
  Gastric body                               14                                     45                                                
  Gastric antrum                             73                                     208                                               
  Whole stomach                              10                                     20                                                
  Pathology classification                                                                                                            
  Adenocarcinoma                             99                                     270                                  2.489        0.477
  Mucous carcinoma                           5                                      10                                                
  Signet ring cell carcinoma                 2                                      13                                                
  Undifferentiated carcinoma                 4                                      18                                                
  Borrmann classification                                                                                                             
  I                                          8                                      11                                   3.830        0.280
  II                                         31                                     75                                                
  III                                        53                                     164                                               
  IV                                         18                                     61                                                
  Adjuvant chemotherapy                                                                                                               
  Yes                                        79                                     217                                  0.163        0.687
  No                                         31                                     94                                                
  Complication                                                                                                                        
  Yes                                        18                                     29                                   4.059        0.044
  No                                         92                                     282                                               
  Lymph node clearance                       20.391 ± 0.693                         23.707 ± 0.587                       3.651        0.000
  Lymph node clearance in different stages                                                                                            
  I                                          13.917 ± 0.558                         20.470 ± 1.010                       3.822        0.000
  II                                         17.863 ± 0.728                         23.402 ± 1.095                       4.231        0.000
  III                                        23.688 ± 0.932                         25.228 ± 0.871                       1.207        0.229

The number of lymph nodes dissection in radical D2 lymphadenectomy for gastric cancer was not only related to the variation of celiac artery but also affected by late tumor stage and high Borrmann typing (*P* \< 0.05)and was not affected by sex, age, tumor location, and pathological type (all *P* \> 0.05) (Table [2](#T2){ref-type="table"}).

###### 

The relationship between the number of lymph nodes dissection and the clinicopathological features of radical D2 lymphadenectomy for gastric cancer

  **Influence factors**        ***n***   **mean ± S**     **SS**     **MS**    ***t* or *F* value**   ***P* value**
  ---------------------------- --------- ---------------- ---------- --------- ---------------------- ---------------
  Gender                                                                                              
  Male                         306       22.869 ± 0.573   \-         \-        0.097                  0.922
  Female                       115       22.765 ± 0.839                                               
  Agein yr                                                                                            
  ≤ 45                         77        23.091 ± 1.313   15.536     7.768     0.081                  0.922
  46-60                        189       22.937 ± 0.625                                               
  \> 60                        155       22.600 ± 0.817                                               
  Variation of celiac artery                                                                          
  Yes                          110       20.391 ± 0.693   \-         \-        3.651                  0.000
  No                           311       23.707 ± 0.587                                               
  Tumor stage                                                                                         
  I                            90        18.722 ± 0.814   \-         \-        13.365                 0.000
  II                           109       22.284 ± 0.910                                               
  III                          222       24.784 ± 0.676                                               
  Tumor location                                                                                      
  Proximal stomach             51        21.588 ± 1.273   510.539    170.180   1.801                  0.146
  Gastric body                 59        21.509 ± 1.199                                               
  Gastric antrum               281       23.000 ± 0.576                                               
  Whole stomach                30        26.100 ± 2.207                                               
  Pathology classification                                                                            
  Adenocarcinoma               369       22.846 ± 0.511   54.376     18.125    0.190                  0.903
  Mucous carcinoma             15        24.333 ± 2.656                                               
  Signet ring cell carcinoma   15        21.733 ± 1.963                                               
  Undifferentiated carcinoma   22        22.500 ± 2.123                                               
  Borrmann classification                                                                             
  I                            19        17.053 ± 1.733   2492.710   830.903   9.261                  0.000
  II                           105       20.171 ± 0.842                                               
  III                          218       23.303 ± 0.655                                               
  IV                           79        26.506 ± 1.165                                               

MS: Mean square;SS: Standard deviation square.

Survival analysis
-----------------

The survival rate at 1, 3, and 5 years in the celiac artery variation group was 84.5%, 57.6%, and 47.6%, respectively. The survival rate at 1, 3, and 5 years in the non-variation group was 85.2%, 56.8%, and 45.2%, respectively. There was no statistical difference in the survival time between the two groups (*χ*^2^ = 0.056, *P* = 0.813) (Figure [3](#F3){ref-type="fig"}).

![Comparison of survival curves of the celiac artery variation group and the normal vessels group.](WJGO-11-499-g003){#F3}

The age, sex, tumor staging, tumor location, pathological type, Borrmann typing, number of lymph nodes, lymph node metastasis, positive lymph node ratio, celiac artery variation, operation time, and intraoperative bleeding amount and postoperative survival of gastric cancer patients were analyzed by univariate Cox regression analysis. The results showed that tumor staging, tumor location, Borrmann typing, operation time, intraoperative bleeding amount, number of lymph nodes dissection, number of lymph node metastases, and positive lymph nodes ratio were prognostic factors of gastric cancer(Table [3](#T3){ref-type="table"}). Variables of statistical significance in univariate Cox regression analysis were introduced into the multivariate Cox regression analysis equation (Forward: LR method), and the selected standard was 0.05. The results showed that tumor stage, intraoperative bleeding amount, and positive lymph node ratio were independent risk factors for prognosis of gastric cancer, as shown in Table [4](#T4){ref-type="table"}.

###### 

The results of univariate Cox regression analysis in gastric cancer

  **Clinicopathological features**   **B**    **SE**   **Wald**   **OR (95%CI)**          ***P* value**
  ---------------------------------- -------- -------- ---------- ----------------------- ---------------
  Age                                0.204    0.104    3.820      1.227(0.999-1.505)      0.051
  Gender                             0.104    0.159    0.429      1.110(0.812-1.517)      0.512
  Tumor stage                        1.004    0.124    65.481     2.728(2.140-3.479)      0.000
  Tumor location                     -0.265   0.088    8.958      0.767 (0.645-0.913)     0.003
  Pathology classification           0.020    0.089    0.050      1.020 (0.857-1.214)     0.823
  Borrmann classification            0.605    0.098    37.822     1.832 (1.511-2.222)     0.000
  Celiac artery variation            0.038    0.163    0.055      1.039 (0.755-1.430)     0.815
  Operation time                     0.002    0.001    8.270      1.002 (1.001-1.003)     0.004
  Intraoperative bleeding            0.001    0.000    21.216     1.001 (1.000-1.001)     0.000
  No. of lymph nodes metastases      0.071    0.008    90.075     1.074 (1.058-1.090)     0.000
  No. of lymph nodes                 0.018    0.007    6.083      1.018 (1.004-1.032)     0.014
  Positive lymph node ratio          2.491    0.242    106.057    12.072 (7.514-19.393)   0.000

###### 

The results of multivariate Cox regression analysis

  **Variables**               **B**   **SE**   **Wald**   **OR (95%CI)**        ***P* value**
  --------------------------- ------- -------- ---------- --------------------- ---------------
  Comprehensive staging       0.626   0.145    18.494     1.870 (1.406-2.486)   0.000
  Intraoperative bleeding     0.001   0.000    10.575     1.001 (1.000-1.001)   0.001
  Positive lymph node ratio   1.466   0.318    21.206     4.330 (2.320-8.079)   0.000

DISCUSSION
==========

At present, D2 lymphadenectomy is widely accepted as the standard of surgery for advanced gastric cancer all around the world. The current 7^th^ UICC/AJCC TNM staging of gastric cancer requires that lymph nodes dissection should include at least 16 or more lymph nodes for histological examination\[[@B2]\]. In recent years, many studies have shown that there is a correlation between the overall survival time and the number of lymph nodes dissection after gastric cancer surgery\[[@B10],[@B11]\]. However, the scope of precise lymph nodes dissection for different stages and tumor locations remains controversial. Lu et al\[[@B12]\] found that radical distal gastrectomy with more than 16 lymph nodes dissection and radical total gastrectomy with more than 21 lymph nodes dissection was the standard and will be more conducive to the analysis and evaluation of the prognosis of the patients. A multicenter study in the United States has shown that clearance of more than 16 lymph nodes in patients with IA-III-A can significantly improve long-term survival\[[@B13]\]. According to the results of a multicenter study including 1654 cases in Germany, more than 25 lymph nodes should be removed for gastric cancer patients with stage II\[[@B3]\]. In a word, the number of lymph nodes dissection in gastric cancer is still controversial. In the era of precision surgery, many scholars suggest that a reasonable range of lymph nodes dissection should be selected according to the individual factors, such as tumor location, tumor staging, and human anatomy, in order to reduce postoperative complications and improve the long-term survival rate and postoperative living quality. The variation of the celiac artery is an important anatomical factor for gastric cancer patients. An earlier study found that the abnormal hepatic artery derived from the superior mesenteric artery was not obviously linked to lymph node distribution\[[@B5]\]. We speculate that the anatomic variation of the celiac artery may affect the number of lymph nodes dissection in gastric cancer.

The results of this study showed that the variation rate of the celiac artery was as high as 26.13%, which was similar to that reported in Ugurel et al\[[@B14]\]. Among them, hepatic artery system variation was the most common, and the abnormal hepatic artery derived from superior mesenteric artery accounted for 43.6% of the hepatic artery system variation, which was a little higher than our previous report(37.0%)\[[@B15]\]. The existence of celiac artery variation increases the difficulty of operation, prolongs the operation time, increases the amount of bleeding during the operation, and may increase the incidences of intraoperative and postoperative complications. Therefore, the surgeon attaches great importance to celiac artery variation\[[@B16]-[@B18]\]. However, the distribution of the lymph nodes around the variant celiac artery has rarely been concerned. The results of this study show that celiac artery variation, tumor stage, and Borrmann typing are factors that affect the lymph nodes dissection of gastric cancer. The higher tumor stage and Borrmann typing, the more lymph nodes could be observed. At present, lymph nodes were sorted with touch method after surgery, which may be associated with overlooking some hidden tiny lymph nodes. High tumor stage and Borrmann typing may increase the rate of lymph node enlargement around the stomach, thus potentially increasing the number of lymph nodes dissection.

The number of lymph nodes dissection in patients with celiac artery variation is significantly less than those without variation, which further validates the prediction of the results in our earlier study. We speculate that the reasons for the reduction of the number of lymph nodes may be as follows. Firstly, the lymphatic reflux system of the stomach is special and complex. Kajitani in Japan suggests that the lymph around the stomach flows retrograde along the artery, and the artery is more fixed. Finally, it was determined to use the trip of the arterial system and the branch of the artery as a fixed anatomical sign to describe the lymph circumfluence of the stomach\[[@B19]\]. Variation of the celiac artery may be accompanied by a change in the lymphatic reflux, leading to a reduction in the distribution of the perivascular lymph nodes. Secondly, the 14^th^ version of the Japanese gastric cancer treatment protocol lists No.12a as a routine cleaning object and No.12p and No.12b as unconventional cleaning objects. The No.12a lymph node is distributed along the hepatic artery from the confluence part of the left and right hepatic duct to the superior border of the pancreas. Normally, the proper hepatic artery goes ahead of the left anterior of the hepatoduodenal ligament and anterior of the portal vein, but the abnormal right hepatic artery and common hepatic artery derived from the superior mesenteric artery are common in the rear of the portal vein and medial of the common bile duct\[[@B20]\].The lymph nodes around this part of the abnormal hepatic artery are easily ignored without dissection during the operation because they are mistaken for No.12b or No.12p, eventually leading to a reduction in the number of lymph nodes dissection. Thirdly, the abnormal arteries, especiallythe abnormal hepatic artery derived from the superior mesenteric artery, are mostly of the post-pancreas type, and it is difficult to dissect the peripheral lymph nodes and adipose tissue around the root of the abnormal hepatic artery and the posterior part of the pancreas.

The number of lymph nodes dissection in the patients with celiac artery variation was not more than those of normal blood vessels, but there was no difference in the prognosis of the two groups. The univariate and multivariate Cox regression analysis showed that the variation of celiac artery was not an independent risk factor for the prognosis of gastric cancer. In view of this, we do not recommend routine cleaning the lymph nodes around the variant celiac artery, especially the abnormal hepatic artery derived from the superior mesenteric artery. The reasons are three points: (1) No lymph nodes are found around the abnormal hepatic artery of the post-pancreas and pre-pancreas type arising from the superior mesenteric artery during the D2 radical lymphadenectomy. Also, the tissues around the abnormal vessels were dissected for routine HE staining and CK20, CEA immunization, and no metastasis was found\[[@B5]\]; (2) The majority of abnormal hepatic arteries derived from the superior mesenteric artery belonged to the post-pancreas type, greatly increasing the difficulty of lymph nodes dissection and the risk of damaging the abnormal hepatic artery and pancreas, which may lead to increased risk of intraoperative bleeding, postoperative liver function damage, and pancreatic fistula and an increase in operation time; and (3) The results of this study showed that the number of lymph nodes dissection was reduced in celiac artery variation patients. However, prognosis was not affected, and the variation of the celiac artery was not an independent risk factor for the prognosis of gastric cancer.

In summary, variation of the celiac artery is an important factor affecting the lymph node clearance of gastric cancer, and the decrease in the number of lymph nodes dissection does not affect the prognosis. We do not recommend routine cleaning for the abnormal hepatic artery, especially the abnormal hepatic artery derived from the superior mesenteric artery. As this study was retrospective, the next step is to perform a prospective control study on the distribution difference of the peripheral lymph nodes based on the detailed vascular variation types, which would yield a more reliable basis for the development of a precise and individualized treatment plan for patients with gastric cancer.

ARTICLE HIGHLIGHTS
==================

Research background
-------------------

The number of lymph nodes dissection directly affects the prognosis and recurrence of gastric cancer. In addition, celiac artery variation is quite common clinically. However, there are few studies that discuss the relationship between celiac artery variation and the number of lymph nodes dissection in gastric cancer surgery.

Research motivation
-------------------

According to our previous study, the number of lymph nodes dissection in gastric cancer surgery might be different between variant celiac artery patients and normal celiac artery patients. Therefore, we conducted this study to investigate the relationship between celiac artery variation and the number of lymph nodes dissection in gastric cancer surgery.

Research objectives
-------------------

To investigate the relationship between celiac artery variation and the number of lymph nodes dissection in radical D2 lymphadenectomy of gastric cancer and the effect on prognosis.

Research methods
----------------

The clinicopathological data of 421 patients treated with radical D2 lymphadenectomy were analyzed retrospectively. The difference in the number of lymph nodes dissection between celiac artery variation group and normal vessels group and the relationship with prognosis were analyzed.

Research results
----------------

The number of lymph nodes dissection in patients with celiac artery variation was significantly less than that of non-variant groups, but there was no significant difference in survival time between the two groups. Univariate and multiple Cox regression analysis showed that celiac artery variation was not a prognostic factor for gastric cancer.

Research conclusions
--------------------

Celiac artery variation is an important factor affecting lymph node clearance in patients with gastric cancer. The number of lymph nodes dissection in patients with celiac artery variation is reduced, but there is no obvious effect on the prognosis. Therefore, lymph nodes around the abnormal artery, especially for the abnormal hepatic artery derived from superior mesenteric artery, may not need to be dissected in radical D2 lymphadenectomy.

Research prospective
--------------------

As this was a small-scale study, we propose future studies with a larger sample sizes. At the same time, the relationship between celiac artery variation and the number of lymph nodes dissection in different celiac artery variation types should be evaluated. We propose that lymph nodes around the abnormal artery, especially for the abnormal hepatic artery derived from superior mesenteric artery, do not need to dissected in radical D2 lymphadenectomy. However, further prospective and controlled studies are required to verify this theory.
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